The patient has received a bone marrow transplant. Soon after the transplant there is a rash on the patient’s skin. She says her skin is itchy and she has severe abdominal pain. What best summarizes what is happening to the patient and how she will be treated?

Questions 83

ATI RN

ATI RN Test Bank

Immune System Quizlet Questions

Question 1 of 5

The patient has received a bone marrow transplant. Soon after the transplant there is a rash on the patient’s skin. She says her skin is itchy and she has severe abdominal pain. What best summarizes what is happening to the patient and how she will be treated?

Correct Answer: C

Rationale: In this scenario, the correct answer is C) Transplanted bone marrow is rejecting her tissue; prevent with immunosuppressive agents. Explanation: When a patient undergoes a bone marrow transplant, there is a risk of graft-versus-host disease (GVHD), where the transplanted immune cells attack the recipient's tissues. Symptoms of GVHD include rash, itching, and abdominal pain. The treatment for GVHD involves using immunosuppressive agents to prevent the transplanted cells from attacking the recipient's tissues. Why other options are wrong: A) Graft rejection occurring; treat with different immunosuppressive agents - This is incorrect as the symptoms described are indicative of GVHD, not graft rejection. B) Dry skin and nausea are side effects of immunosuppressants; decrease the dose - This is incorrect as the symptoms are more likely due to GVHD rather than side effects of immunosuppressants. D) Dry skin from the dry air and nausea from the food in the hospital; treat with humidifier and home food - This is incorrect as the symptoms are not likely related to environmental factors but rather to the immune response post-transplant. Educational context: Understanding the complications and management of bone marrow transplants, including GVHD, is crucial for healthcare professionals involved in caring for transplant patients. Recognizing the signs and symptoms of GVHD and knowing the appropriate treatment options is essential for ensuring the best outcomes for patients undergoing bone marrow transplants.

Question 2 of 5

Prophylactic measures that are routinely used as early as possible in HIV infection to prevent opportunistic and debilitating secondary problems include administration of

Correct Answer: C

Rationale: The correct answer is C) vaccines for pneumococcal pneumonia, influenza, and hepatitis A and B. Explanation: In HIV infection, the immune system is compromised, making individuals more susceptible to infections. Administering vaccines against these specific pathogens helps prevent serious secondary problems by bolstering the immune response against these infectious agents. Pneumococcal pneumonia, influenza, and hepatitis A and B are common infections that can have severe consequences in immunocompromised individuals. By vaccinating early in HIV infection, the chances of developing these infections are significantly reduced, leading to better health outcomes. Why the other options are wrong: A) Isoniazid (INH) is used to prevent tuberculosis, which is not a routine prophylactic measure in early HIV infection. B) Trimethoprim/sulfamethoxazole (TMP/SMX) is used for preventing certain opportunistic infections but not as a routine prophylactic measure in early HIV infection. D) Varicella-zoster immune globulin (VZIG) is used to prevent chickenpox or shingles but is not routinely administered in early HIV infection for prophylaxis against opportunistic infections. Educational context: Understanding the importance of prophylactic measures in HIV infection is crucial for healthcare providers managing patients with HIV. Vaccination plays a key role in preventing opportunistic infections and improving the overall health outcomes of individuals living with HIV. It is essential to prioritize early intervention strategies like vaccination to protect against common pathogens and reduce the burden of secondary complications in this vulnerable population.

Question 3 of 5

The patient was told she has carcinoma in situ, and the student nurse wonders what that is. How should the nurse explain this to the student nurse?

Correct Answer: B

Rationale: The correct answer is B) Lesion with histologic features of cancer except invasion. Carcinoma in situ refers to abnormal cells that are present only in the layer of cells in which they developed, without invading deeper tissues. This is an important concept in oncology because it signifies a very early stage of cancer that has not yet spread. By understanding this distinction, healthcare providers can make informed decisions about treatment and prognosis. Option A) Evasion of the immune system by cancer cells is incorrect because it describes a different concept related to how cancer cells can avoid detection and destruction by the immune system. Option C) Capable of causing cellular alterations associated with cancer is incorrect as it is a vague statement that does not specifically define carcinoma in situ. Option D) Tumor cell surface antigens that stimulate an immune response is incorrect as it describes the interaction between tumor cells and the immune system, which is not the defining characteristic of carcinoma in situ. In an educational context, understanding the stages of cancer development is crucial for healthcare professionals to provide accurate information to patients, make appropriate referrals, and coordinate care effectively. Knowing the differences between carcinoma in situ and invasive cancer is essential for accurate diagnosis and treatment planning.

Question 4 of 5

For which type of malignancy should the nurse expect the use of the intravesical route of regional chemotherapy delivery?

Correct Answer: A

Rationale: In the context of pharmacology and regional chemotherapy delivery, the correct answer is A) Bladder. Intravesical route refers to the administration of drugs directly into the bladder, making it an ideal route for treating bladder malignancies. The rationale behind this choice lies in the proximity of the drug delivery to the site of action, maximizing drug concentration in the bladder while minimizing systemic exposure and side effects. Option B) Leukemia is incorrect because leukemia is a systemic malignancy that affects the bone marrow and blood, making intravesical delivery irrelevant for this type of malignancy. Option C) Osteogenic sarcoma is incorrect because this type of malignancy originates in the bones, and intravesical delivery is not suitable for treating bone-related cancers. Option D) Metastasis to the brain is incorrect as intravesical delivery is not used to treat brain metastases. The blood-brain barrier limits the passage of drugs into the brain, necessitating other routes of administration. Educationally, understanding the rationale behind choosing the correct route of drug administration based on the type and location of malignancy is crucial for healthcare professionals. It ensures effective and targeted treatment while minimizing systemic side effects. This knowledge enhances patient care and outcomes by optimizing the therapeutic benefits of chemotherapy.

Question 5 of 5

An allogenic hematopoietic stem cell transplant is considered as treatment for a patient with acute myelogenous leukemia. What information should the nurse include when teaching the patient about this procedure?

Correct Answer: C

Rationale: In this scenario, option C is the correct answer. When educating the patient about an allogenic hematopoietic stem cell transplant for acute myelogenous leukemia, it is crucial to include information about how peripheral stem cells are obtained from a donor who has a human leukocyte antigen (HLA) match with the patient. This is essential for successful engraftment and to minimize the risk of graft rejection or graft-versus-host disease. Option A is incorrect because even though the donated marrow is treated to remove cancer cells, there is still a risk of graft-versus-host disease due to HLA incompatibility. Option B is incorrect as it describes an autologous stem cell transplant procedure where the patient's own bone marrow is harvested and reinfused after treatment. Option D is incorrect as posttransplant protective isolation is usually necessary to prevent infections due to the patient's compromised immune system post-transplant. Educationally, understanding the importance of HLA matching in allogenic stem cell transplants is vital for patients and healthcare providers to grasp the rationale behind the procedure and the potential risks involved. It emphasizes the need for close monitoring and supportive care post-transplant to ensure the best possible outcomes for the patient.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions